Visit https://www.peervoice.com/AUK860 to view the entire programme with slides. After completing “Optimizing Care in Patients With Recurrent Head and Neck Squamous Cell Carcinoma”, participants will be able to: Evaluate the data of immunotherapy treatment options as monotherapy and combination for patients with recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC); and Identify patients who would benefit from immunotherapies for the management of R/M HNSCC.